Corrigendum: Dosage Modification of Traditional Chinese Medicine Prescriptions: An Analysis of Two Randomized Controlled Trials
Year: 2022
Type: erratum
Abstract: **No. 81274000 and No. 2010CB530600** to **Fengmei Lian**. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.In the original article, there was a mistake in the legend for ** Figure 2 Figure 6 The verification procedure diagram of the strategy of dosage modification. The difference value between the week 4 and the week 8 was recorded as FBG 04*. FBG04 ≥ 0.5 mmol/L obtained from analysis of study1. FBG 04* ≥ 0.3 mmol/L obtained from analysis of the high-dose group in study 2. The intervention group and the control group were the fixed-dose group and the unfixed-dose group respectively, and the initial dose was the same in both groups. In addition, the dose was fixed at 12 weeks in the fixed-dose group. In the unfixed-dose group, we continued the initial dose at week 4 when the decreasing range of FBG level at week 4 from baseline (FBG 04*) was greater than 0.5 mmol/L and increased the dose at week 4 when the decreasing range of FBG level at week 4 from baseline was less than 0.5 mmol/L. For week 8, increased the dose at week 8 if the decreasing range of FBG level at week 8 from week 4 was less than 0.3 mmol/L. If the decrease of FBG level was more than 0.3 mmol/L at the week 8 from the week 4, then it would indicate that the dose was large enough and dose unchanged. Finally, the outcomes were analyzed at week 12. **
Source: Frontiers in Pharmacology
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,950
OpenAlex ID: W4221069698